INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021

May 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-05-13

Reporting Person: DANSEY ROGER D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-13	Common Stock Options	$6.23	A	54000	Acquired	2031-05-13	Common Stock (54000.0)	Direct
2021-05-13	Restricted Stock Unit	$	A	36000	Acquired		Common Stock (36000.0)	Direct

Footnotes

F1: This grant was made pursuant to the issuer's non-employee director compensation policy.

F2: The vesting schedule for the 54,000 options is as follows: 13,500 shares vested on May 13, 2021; 13,500 shares will vest on May 13, 2022; 13,500 shares will vest on May 13, 2023; 13,500 shares will vest on May 13, 2024.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares will vest on May 13, 2022; 12,000 shares will vest on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.